EUVIMEDOpdag EUVIMED
Video/Audio

Resveratrol Suppresses Lung Cancer through the NLRP3/IL-1β Signaling Axis to Improve Immune Microenvironment​

Hongting Sui, Zhiguo Lin, Xiaodie Zheng, Bo Li, Wenshuang Dai, Qingyuan Zhu, Danyang Li, Chao Wu, Ting Cao

Journal of Visualized Experiments · 2026

DOI: 10.3791/70137 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Hongting Sui and 8 co-authors. Institution: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Qiqihar Medical University; zhile1968@yeah.net. Major MEDLINE topics: NLR Family, Pyrin Domain-Containing 3 Protein, Lung Neoplasms, Interleukin-1beta, Stilbenes. Cited 1 times so far (Crossref); 34 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The incidence and mortality rates of lung cancer remain high, posing a serious threat to human health. This study aims to investigate the role of resveratrol in lung cancer and its regulatory mechanism on the immune microenvironment. Human lung cancer A549 cells were treated with different concentrations of resveratrol, and a syngeneic mouse model of lung cancer was established to evaluate the effects of resveratrol and the NLRP3 inhibitor MCC950 on cell growth and the expression of NLRP3/IL-1β. Meanwhile, tumor growth, cell apoptosis, T cell infiltration, and the expression of key signaling proteins were examined in vivo. The results showed that resveratrol significantly inhibited the proliferation of A549 cells, induced cell cycle arrest and apoptosis, and was accompanied by reduced expression of NLRP3 and IL-1β. In the syngeneic mouse model of lung cancer, resveratrol treatment suppressed tumor cell proliferation, improved tumor morphology, enhanced T lymphocyte infiltration, and concurrently decreased the expression of NLRP3, IL-1β, ASC, and cleaved-caspase-1. These findings indicate that resveratrol inhibits tumor growth and remodels the immune microenvironment by targeting the NLRP3/IL-1β signaling axis, offering new insights and potential strategies for lung cancer immunotherapy.

Subjects

MeSH terms (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinLung NeoplasmsInterleukin-1betaStilbenesTumor MicroenvironmentAnimalsResveratrolHumansSignal TransductionMiceA549 CellsCell Proliferation

Substances

NLR Family, Pyrin Domain-Containing 3 ProteinResveratrolInterleukin-1betaStilbenesNLRP3 protein, human

Authors and institutions

  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Qiqihar Medical University; zhile1968@yeah.net.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Qiqihar Medical University.
  • Department of Respiratory and Critical Care Medicine,, Qiqihar Medical University.
  • Department of Cardiovascular Medicine, the First People's Hospital of Keshan County.
  • Department of Neurology, The First Affiliated Hospital of Qiqihar Medical University.
  • School of Nursing, Qiqihar Medical University.

Cite

APA

Sui, H., Lin, Z., Zheng, X., Li, B., Dai, W., Zhu, Q., Li, D., Wu, C., & Cao, T. (2026). Resveratrol Suppresses Lung Cancer through the NLRP3/IL-1β Signaling Axis to Improve Immune Microenvironment​. Journal of Visualized Experiments. https://doi.org/10.3791/70137

Vancouver

Sui H, Lin Z, Zheng X, Li B, Dai W, Zhu Q, et al. Resveratrol Suppresses Lung Cancer through the NLRP3/IL-1β Signaling Axis to Improve Immune Microenvironment​. Journal of Visualized Experiments. 2026. doi:10.3791/70137

BibTeX
@article{Sui2026,
  author = {Sui, Hongting and Lin, Zhiguo and Zheng, Xiaodie and Li, Bo and Dai, Wenshuang and Zhu, Qingyuan and Li, Danyang and Wu, Chao and Cao, Ting},
  title = {Resveratrol Suppresses Lung Cancer through the NLRP3/IL-1β Signaling Axis to Improve Immune Microenvironment​},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70137}
}
Start for free →